Funder: National Institutes of Health

Due Dates: June 12, 2025 (New) | July 12, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 12, 2025 (New) | November 12, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 12, 2026 (New) | March 12, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 12, 2026 (New) | July 12, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 12, 2026 (New) | November 12, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | February 12, 2027 (New) | March 12, 2027 (Renewal/Resubmission/Revision) | May 7, 2027 (AIDS) | June 12, 2027 (New)

Funding Amounts: Salary and research support for up to 5 years; award budgets include salary, fringe benefits, and research-related expenses as determined by participating NIH Institutes/Centers.

Summary: Supports career development of clinicians committed to patient-oriented research, specifically for independent basic experimental studies with humans (K23 mechanism).

Key Information: Applicants must propose basic experimental studies with humans that meet both NIH clinical trial and basic research definitions; prior consultation with NIH staff and review of IC-specific requirements is strongly encouraged.